V. Appel

发表

Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

S H Appel, L. Haverkamp, V. Appel, 1995, Brain : a journal of neurology.

Effects of cyclosporine therapy on plasma lipoprotein levels.

A. Gotto, C. Ballantyne, V. Appel, 1989, JAMA.

Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis.

B. Diamond, V. Appel, S. Appel, 1998, Archives of neurology.

A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience

G. Smith, V. Appel, S. Appel, 1987, Annals of neurology.

Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease.

L. Haverkamp, V. Appel, S. Appel, 1996, The Lancet.

Apolipoprotein E ɛ4 in bulbar-onset motor neuron disease

L. Haverkamp, V. Appel, S. Appel, 1996, The Lancet.

lateral sclerosis . neuropsychological deficits in amyotrophic Prevalence and correlates of

P. Massman, L. Haverkamp, V. Appel, 2003 .

Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

P. Massman, L. Haverkamp, V. Appel, 1996, Journal of neurology, neurosurgery, and psychiatry.

A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis.

V. Appel, S. Appel, W. Mietlowski, 1988, Archives of neurology.

Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

P. Massman, L. Haverkamp, V. Appel, 1996, Journal of neurology, neurosurgery, and psychiatry.